Captor Capital Competitors

Captor Capital (OTCMKTS:CPTRF) and Santa Fe Gold (OTCMKTS:SFEG) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, profitability, valuation and risk.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Captor Capital and Santa Fe Gold, as provided by MarketBeat.

Valuation and Earnings

This table compares Captor Capital and Santa Fe Gold's gross revenue, earnings per share and valuation.

Santa Fe Gold has lower revenue, but higher earnings than Captor Capital.

Profitability

This table compares Captor Capital and Santa Fe Gold's net margins, return on equity and return on assets.

Risk and Volatility

Captor Capital has a beta of 2.96, indicating that its stock price is 196% more volatile than the S&P 500. Comparatively, Santa Fe Gold has a beta of -0.22, indicating that its stock price is 122% less volatile than the S&P 500.

Insider & Institutional Ownership

0.2% of Captor Capital shares are held by institutional investors. 3.7% of Santa Fe Gold shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Santa Fe Gold beats Captor Capital on 5 of the 8 factors compared between the two stocks.

Lexaria Bioscience (OTCMKTS:LXRP) and Captor Capital (OTCMKTS:CPTRF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Analyst Ratings

This is a breakdown of current ratings and price targets for Lexaria Bioscience and Captor Capital, as provided by MarketBeat.com.

Earnings & Valuation

This table compares Lexaria Bioscience and Captor Capital's gross revenue, earnings per share (EPS) and valuation.

Lexaria Bioscience has higher earnings, but lower revenue than Captor Capital.

Profitability

This table compares Lexaria Bioscience and Captor Capital's net margins, return on equity and return on assets.

Insider and Institutional Ownership

0.1% of Lexaria Bioscience shares are held by institutional investors. Comparatively, 0.2% of Captor Capital shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Captor Capital beats Lexaria Bioscience on 5 of the 6 factors compared between the two stocks.

American Lithium Minerals (OTCMKTS:AMLM) and Captor Capital (OTCMKTS:CPTRF) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Analyst Ratings

This is a breakdown of current ratings and price targets for American Lithium Minerals and Captor Capital, as provided by MarketBeat.com.

Earnings & Valuation

This table compares American Lithium Minerals and Captor Capital's gross revenue, earnings per share (EPS) and valuation.

American Lithium Minerals has higher earnings, but lower revenue than Captor Capital.

Profitability

This table compares American Lithium Minerals and Captor Capital's net margins, return on equity and return on assets.

Volatility and Risk

American Lithium Minerals has a beta of 2.46, indicating that its stock price is 146% more volatile than the S&P 500. Comparatively, Captor Capital has a beta of 2.96, indicating that its stock price is 196% more volatile than the S&P 500.

Insider and Institutional Ownership

0.2% of Captor Capital shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Alderon Iron Ore (OTCMKTS:AXXDF) and Captor Capital (OTCMKTS:CPTRF) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Analyst Ratings

This is a breakdown of current ratings and price targets for Alderon Iron Ore and Captor Capital, as provided by MarketBeat.com.

Earnings & Valuation

This table compares Alderon Iron Ore and Captor Capital's gross revenue, earnings per share (EPS) and valuation.

Alderon Iron Ore has higher earnings, but lower revenue than Captor Capital.

Profitability

This table compares Alderon Iron Ore and Captor Capital's net margins, return on equity and return on assets.

Volatility and Risk

Alderon Iron Ore has a beta of 2.65, indicating that its stock price is 165% more volatile than the S&P 500. Comparatively, Captor Capital has a beta of 2.96, indicating that its stock price is 196% more volatile than the S&P 500.

Insider and Institutional Ownership

0.2% of Captor Capital shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Alderon Iron Ore beats Captor Capital on 4 of the 7 factors compared between the two stocks.

New Age Metals (OTCMKTS:NMTLF) and Captor Capital (OTCMKTS:CPTRF) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Analyst Ratings

This is a breakdown of current ratings and price targets for New Age Metals and Captor Capital, as provided by MarketBeat.com.

Earnings & Valuation

This table compares New Age Metals and Captor Capital's gross revenue, earnings per share (EPS) and valuation.

New Age Metals has higher earnings, but lower revenue than Captor Capital.

Profitability

This table compares New Age Metals and Captor Capital's net margins, return on equity and return on assets.

Volatility and Risk

New Age Metals has a beta of 4.54, indicating that its stock price is 354% more volatile than the S&P 500. Comparatively, Captor Capital has a beta of 2.96, indicating that its stock price is 196% more volatile than the S&P 500.

Insider and Institutional Ownership

0.2% of Captor Capital shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

New Age Metals beats Captor Capital on 5 of the 7 factors compared between the two stocks.

Lomiko Metals (OTCMKTS:LMRMF) and Captor Capital (OTCMKTS:CPTRF) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Earnings & Valuation

This table compares Lomiko Metals and Captor Capital's gross revenue, earnings per share (EPS) and valuation.

Lomiko Metals has higher earnings, but lower revenue than Captor Capital.

Analyst Ratings

This is a breakdown of current ratings and price targets for Lomiko Metals and Captor Capital, as provided by MarketBeat.com.

Volatility and Risk

Lomiko Metals has a beta of 3.02, indicating that its stock price is 202% more volatile than the S&P 500. Comparatively, Captor Capital has a beta of 2.96, indicating that its stock price is 196% more volatile than the S&P 500.

Profitability

This table compares Lomiko Metals and Captor Capital's net margins, return on equity and return on assets.

Insider and Institutional Ownership

0.2% of Captor Capital shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.